Page last updated: 2024-08-24

cilazapril, anhydrous and Coronary Artery Disease

cilazapril, anhydrous has been researched along with Coronary Artery Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heyndrickx, GR	1

Trials

1 trial(s) available for cilazapril, anhydrous and Coronary Artery Disease

Article	Year
Angiotensin-converting enzyme inhibitor in a human model of restenosis. MERCATOR ("Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis") Study Group. Basic research in cardiology, 1993, Volume: 88 Suppl 1 Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Follow-Up Studies; Humans	1993

Article

Year

Angiotensin-converting enzyme inhibitor in a human model of restenosis. MERCATOR ("Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis") Study Group.

Basic research in cardiology, 1993, Volume: 88 Suppl 1

Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Follow-Up Studies; Humans

1993